SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-012352
Filing Date
2018-05-10
Accepted
2018-05-10 16:44:46
Documents
1
Period of Report
2018-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3371
  Complete submission text file 0000899243-18-012352.txt   4767
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 711 HARVEST HILL ROAD CHALFONT PA 18914
Business Address
Pomerantz Roger (Reporting) CIK: 0001614936 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 18823609